Stock Events

Stock Events

SK Biopharmaceuticals. (326030.KQ) Q4 2024 Earnings

8NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-33.1

81.54

196.17

310.81

Details

Expected EPS

129.8155426848

Actual EPS

84.7313534844

Surprise EPS

-45.08

Surprise Percent

+34.73%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 84.7313534844 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.